CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer
Authors
A O’Donnell
BM Wolpin
+41 more
CJ Punt
D. J. Richel
DT Milton
EA Gehan
F Andre
G Bodoky
H Seeliger
H Seeliger
H. J. Klümpen
HA Burris 3rd
I Beuvink
I Okamoto
J Baselga
J Cassidy
J LoPiccolo
J Tabernero
J. H. M. Schellens
J. W. Wilmink
JC Soria
JC Yao
JD Hainsworth
K Zitzmann
KJ Labori
M Aoki
M Campone
M Joka
M. J. Weterman
MJ Deenen
P Therasse
RJ Amato
RJ Motzer
S Faivre
S Mabuchi
S. Kordes
SJ Lee
SL Ellard
SS Khariwala
T Conroy
T Matsuzaki
TH Cartwright
X Bu
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs00280-015-...
Last time updated on 01/04/2019
